Skip to main content

Table 2 Antibodies utilized for immuno-histochemical detection

From: p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading

Target protein

Antibody

Type

Provider

Bax

p-19a

polyclonal

Santa Cruz

Bcl-2

100/D5

polyclonal

Novocastra/YLEM

Cathepsin D

cat-D

polyclonal

DAKO

Cyclin D1

DCS6

monoclonal

Novocastra/YLEM

Cyclin E

13A3

monoclonal

Novocastra/YLEM

ERα

MU368-UC

monoclonal

Biogenex

Her-2/erb-B/neu

Hercep-test

polyclonal

DAKO

Ki-67

MIB-1

monoclonal

Novocastra/YLEM

p16/INK4

p16

polyclonal

Pharmingen

p27/kip1

F-8

monoclonal

Santa Cruz

p53

DO7

monoclonal

NeoMarkers

PAI-1

sc-6642

polyclonal

Santa Cruz

PgR

1A6

polyclonal

Ventana

Stromelysin/MMP11

sc-8837

polyclonal

Santa Cruz

uPA

sc-6830

polyclonal

Santa Cruz

  1. aantibodies were utilized as described in Methods